Compare Sublocade to Other Buprenorphine Forms for Opioid Dependence

March 2018

New practice changes and dosage forms will give you more opportunities to prescribe buprenorphine for opioid use disorder.

Recent DEA rules allow NPs and PAs in some states to become certified buprenorphine prescribers with an "X" DEA number.

And new Sublocade (SUB-loh-kayd) will join Probuphine as another long-acting buprenorphine product. Sublocade is a once-monthly subcutaneous injection...Probuphine is an implant that lasts 6 months.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Vaccines Be Ready to Give MMR Boosters During a Mumps Outbreak
Pregnancy Weigh Pros and Cons of Antibiotic Options for UTI in Pregnancy
Hyperglycemia Reassure Diabetes Patients With Glucose Bumps Due to Short-Course Steroids
Pediatrics Consider Alternatives to Opioids for Cough or Pain in Children
Med Adherence Consider Approaches to Help Patients Adhere to Meds
Influenza Don't Rely on Supplements Instead of Antivirals to Treat Influenza
Substance Use Disorder Compare Sublocade to Other Buprenorphine Forms for Opioid Dependence
Medicare Ensure Your Practice Is Ready for New Medicare Cards
Poison Prevention Be Ready With Tips to Help Prevent and Manage Poisonings
Obesity & Weight Loss Monitor and Adjust Meds After Weight Loss Surgery
Anticoagulants Watch for the Anticoagulant Bevyxxa During Transitions of Care

Compare Sublocade to Other Buprenorphine Forms for Opioid Dependence

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents